Statins
Sort by:
The Texas Heart Institute
Insights into Triglyceride Reduction: What Do the Treatment Guidelines Tell Us and Why?
FEATURING
Salim Virani
- 410 views
- April 22, 2021
- 2
The Texas Heart Institute
Triglyceride Lowering Therapies: What Have We Recently Learned? What Is Coming Down the Pipeline?
FEATURING
Salim Virani
- 1,096 views
- April 22, 2021
- 6
The Texas Heart Institute
Menopause vs. Manopause: Why Have the CVD Rates of Death Been on the Decline? Is Menapause a Risk Factor?
FEATURING
Stephanie Coulter
- 235 views
- April 20, 2021
- 1
American Heart & Vascular Institute
Icosapent Ethyl for Patients With HTG: A New Paradigm in CVD Prevention
FEATURING
Eliot Brinton
- 244 views
- April 8, 2021
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 924 views
- February 5, 2021
- 11